Click here to narrow your options by answering a few questions.
   

Prostate Cancer Treatment Guide

Prostate Cancer Glossary

 

 

A   B   C   D   E

F   G   H   I   J

K   L   M   N   O

P   Q   R   S   T

U   V   W   X   Y   Z

Brachytherapy

Chemotherapy

Cryotherapy & Cryosurgery

Hormone
Therapy

Radiation
Therapy

Prostatectomy

Robotic Prostatectomy

Watchful
Waiting

Complementary
and
Alternative Medicine

High Intensity
Focused
Ultrasound (HIFU)

Emerging Technologies

 

Biochemical Progression Free Survival
and Prostate Cancer


Biochemical Progression Free Survival means that after undergoing a prostate cancer treatment the patientís PSA level does not rise for 2 to 3 consecutive. Biochemical relapse free survival should not be confused with overall survival. Overall survival when used in a clinical sense refers only to those who did not die as a result of their prostate cancer at the time of follow-up. Many doctors believe that there is comparative difference in the overall survival rates, possibly due to the unusually slow growth rate common in most types of prostate cancers.

Biochemical relapse free survival is a more specific term. The word biochemical refers to the use of the prostate-specific antigen as a tumor marker. If the patient relapses biochemically, his PSA level has risen significantly. Generally, patients who undergo a prostate cancer treatment should have nearly undetectable PSA levels, somewhere around or under 1.0 ng/mL. Those with a high PSA velocity after treatment have experienced biochemical relapse, but they have not died. Biochemical relapse, however, is a reasonable indicator of who will develop recurrent prostate cancer.

 

 
 

 
 
Prostate Cancer Discussion Group
 
 

Coping with Prostate Cancer      Are You at Risk for Prostate Cancer?      Prostate Cancer News     Glossary

 Home     Contact Us     Disclaimer    Privacy Policy     Resources     Add URL      Site Map